190 related articles for article (PubMed ID: 28744693)
1. VEGFA Involves in the Use of Fluvastatin and Zoledronate Against Breast Cancer.
Pu H; Zhang Q; Zhao C; Shi L; Wang Y; Wang J; Zhang M
Pathol Oncol Res; 2018 Jul; 24(3):557-565. PubMed ID: 28744693
[TBL] [Abstract][Full Text] [Related]
2. Expression of matrix macromolecules and functional properties of breast cancer cells are modulated by the bisphosphonate zoledronic acid.
Dedes PG; Gialeli Ch; Tsonis AI; Kanakis I; Theocharis AD; Kletsas D; Tzanakakis GN; Karamanos NK
Biochim Biophys Acta; 2012 Dec; 1820(12):1926-39. PubMed ID: 22884656
[TBL] [Abstract][Full Text] [Related]
3. Synergistic suppression of human breast cancer cells by combination of plumbagin and zoledronic acid In vitro.
Qiao H; Wang TY; Yan W; Qin A; Fan QM; Han XG; Wang YG; Tang TT
Acta Pharmacol Sin; 2015 Sep; 36(9):1085-98. PubMed ID: 26235741
[TBL] [Abstract][Full Text] [Related]
4. Transcriptome analysis and in vivo activity of fluvastatin versus zoledronic acid in a murine breast cancer metastasis model.
Vintonenko N; Jais JP; Kassis N; Abdelkarim M; Perret GY; Lecouvey M; Crepin M; Di Benedetto M
Mol Pharmacol; 2012 Sep; 82(3):521-8. PubMed ID: 22723339
[TBL] [Abstract][Full Text] [Related]
5. Inhibitors of the mevalonate pathway as potential therapeutic agents in multiple myeloma.
Baulch-Brown C; Molloy TJ; Yeh SL; Ma D; Spencer A
Leuk Res; 2007 Mar; 31(3):341-52. PubMed ID: 16996129
[TBL] [Abstract][Full Text] [Related]
6. Down-regulation of CITED2 attenuates breast tumor growth, vessel formation and TGF-β-induced expression of VEGFA.
Jayaraman S; Doucet M; Kominsky SL
Oncotarget; 2017 Jan; 8(4):6169-6178. PubMed ID: 28008154
[TBL] [Abstract][Full Text] [Related]
7. Antitumor Effects of Ruyiping on Cell Growth and Metastasis in Breast Cancer.
Li Z; Sun X; Liu X; Sun Z; Li J
Cancer Biother Radiopharm; 2019 Jun; 34(5):297-305. PubMed ID: 30901274
[No Abstract] [Full Text] [Related]
8. Fluvastatin, a lipophilic statin, induces apoptosis in human hepatocellular carcinoma cells through mitochondria-operated pathway.
Zhang W; Wu J; Zhou L; Xie HY; Zheng SS
Indian J Exp Biol; 2010 Dec; 48(12):1167-74. PubMed ID: 21250597
[TBL] [Abstract][Full Text] [Related]
9. Statin-induced inhibition of breast cancer proliferation and invasion involves attenuation of iron transport: intermediacy of nitric oxide and antioxidant defence mechanisms.
Kanugula AK; Gollavilli PN; Vasamsetti SB; Karnewar S; Gopoju R; Ummanni R; Kotamraju S
FEBS J; 2014 Aug; 281(16):3719-38. PubMed ID: 24964743
[TBL] [Abstract][Full Text] [Related]
10. An Integrated Systems Biology and Network-Based Approaches to Identify Novel Biomarkers in Breast Cancer Cell Lines Using Gene Expression Data.
Khan A; Rehman Z; Hashmi HF; Khan AA; Junaid M; Sayaf AM; Ali SS; Hassan FU; Heng W; Wei DQ
Interdiscip Sci; 2020 Jun; 12(2):155-168. PubMed ID: 32056139
[TBL] [Abstract][Full Text] [Related]
11. Zoledronic acid (Zometa) enhances the cytotoxic effect of gemcitabine and fluvastatin: in vitro isobologram studies with conventional and nonconventional cytotoxic agents.
Budman DR; Calabro A
Oncology; 2006; 70(2):147-53. PubMed ID: 16645328
[TBL] [Abstract][Full Text] [Related]
12. Silencing of ANXA3 expression by RNA interference inhibits the proliferation and invasion of breast cancer cells.
Zhou T; Li Y; Yang L; Liu L; Ju Y; Li C
Oncol Rep; 2017 Jan; 37(1):388-398. PubMed ID: 27878264
[TBL] [Abstract][Full Text] [Related]
13. Knockdown of SF3B1 inhibits cell proliferation, invasion and migration triggering apoptosis in breast cancer via aberrant splicing.
Zhang L; Zhang X; Zhang H; Liu F; Bi Y; Zhang Y; Cheng C; Liu J
Breast Cancer; 2020 May; 27(3):464-476. PubMed ID: 31919642
[TBL] [Abstract][Full Text] [Related]
14. CTEN Inhibits Tumor Angiogenesis and Growth by Targeting VEGFA Through Down-Regulation of β-Catenin in Breast Cancer.
Lu X; Zhou B; Cao M; Shao Q; Pan Y; Zhao T
Technol Cancer Res Treat; 2021; 20():15330338211045506. PubMed ID: 34817293
[TBL] [Abstract][Full Text] [Related]
15. Vascular endothelial growth inhibitor affects the invasion, apoptosis and vascularisation in breast cancer cell line MDA-MB-231.
Gao Y; Ge Z; Zhang Z; Bai Z; Ma X; Wang Y
Chin Med J (Engl); 2014; 127(10):1947-53. PubMed ID: 24824261
[TBL] [Abstract][Full Text] [Related]
16. A novel all-trans retinoid acid derivatives inhibits the migration of breast cancer cell lines MDA-MB-231 via myosin light chain kinase involving p38-MAPK pathway.
Wang B; Yan Y; Zhou J; Zhou Q; Gui S; Wang Y
Biomed Pharmacother; 2013 Jun; 67(5):357-62. PubMed ID: 23602051
[TBL] [Abstract][Full Text] [Related]
17. Terrein inhibits migration of human breast cancer cells via inhibition of the Rho and Rac signaling pathways.
Kasorn A; Loison F; Kangsamaksin T; Jongrungruangchok S; Ponglikitmongkol M
Oncol Rep; 2018 Mar; 39(3):1378-1386. PubMed ID: 29328460
[TBL] [Abstract][Full Text] [Related]
18. Fluvastatin inhibits growth and alters the malignant phenotype of the C6 glioma cell line.
Sławińska-Brych A; Zdzisińska B; Kandefer-Szerszeń M
Pharmacol Rep; 2014 Feb; 66(1):121-9. PubMed ID: 24905317
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of transendothelial migration and invasion of human breast cancer cells by preventing geranylgeranylation of Rho.
Kusama T; Mukai M; Tatsuta M; Nakamura H; Inoue M
Int J Oncol; 2006 Jul; 29(1):217-23. PubMed ID: 16773203
[TBL] [Abstract][Full Text] [Related]
20. Activity of mevalonate pathway inhibitors against breast and ovarian cancers in the ATP-based tumour chemosensitivity assay.
Knight LA; Kurbacher CM; Glaysher S; Fernando A; Reichelt R; Dexel S; Reinhold U; Cree IA
BMC Cancer; 2009 Jan; 9():38. PubMed ID: 19175937
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
